Drugs Made In America Acquisition II Corp. (DMII) stock
Close on Nov 13, 2026Market cap $140.29MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $140.29M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $13.02M
Trading
- Previous close
- $10.24
- Open
- $10.24
- Day's range
- $10.24 – $10.24
- Volume
- 150,071
- Average volume (20 days)
- 112,144
- 52-week range
- $9.86 – $10.33
- RSI (14 days)
- 71.5
- Volatility (1 year)
- 1.7%
- Relative volume
- 1.53×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | DMII | S&P 500 | Difference | DMII per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.5% | -3.0% | +3.5 pts | ||
| 3 months | +1.1% | -2.8% | +3.9 pts | ||
| Year to date | +3.4% | +11.5% | −8.1 pts |
Two years at a glance
Fiscal years 2024 to 2025 and trailing twelve months, USD
Operating income
Net income
Press releases
Releases Drugs Made In America Acquisition II filed with the SEC as exhibits to Form 8-K or 6-K
About Drugs Made In America Acquisition II
Blank Checks
Drugs Made In America Acquisition II Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company conducts no commercial operations and generates no revenue, operating solely as a shell company. Its business strategy focuses on acquiring operating entities in the pharmaceutical sector, specifically targeting businesses capable of advancing the domestic manufacturing of active pharmaceutical ingredients and critical finished generic drugs to enhance supply chain resilience.
Company profile, executives and historyDrugs Made In America Acquisition II stock: common questions
What is Drugs Made In America Acquisition II's stock price?
DMII closed at $10.24 on Nov 13, 2026, down 0.05% on the day. Over the past 52 weeks it traded between $9.86 and $10.33.
What is Drugs Made In America Acquisition II's market cap?
Drugs Made In America Acquisition II was worth $140.29M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
Does Drugs Made In America Acquisition II pay a dividend?
No. Drugs Made In America Acquisition II has not paid a cash dividend over the last twelve months.
Who are Drugs Made In America Acquisition II's competitors?
Companies most similar to Drugs Made In America Acquisition II by business, industry and size include DMAA, OIM, TACO, PGAC, DYOR.
See a number that looks wrong?